HKHC 最新10-Q变化
将 HKHC 最新的定期申报(10-K/10-Q)与上一份同类型申报逐章节对比:每个章节新增/删除的段落数与原文摘录。全部为确定性文本对比——无相似度评分、无方向判断、非投资建议。
对比:10-Q · 2026-08-13 与上一份 10-Q · 2026-05-15
| 章节 | 结果 | 新增 | 删除 | 微调 | 未变 |
|---|---|---|---|---|---|
| 管理层讨论与分析 | 文字有新增/删除 | +32 | −10 | ~30 | 26 |
| 控制与程序 | 文字有新增/删除 | 0 | 0 | ~2 | 0 |
| 风险因素 | 无段落级文字变化 | 0 | 0 | 0 | 2 |
计数单位为段落;"新增/删除"指相对上一份文件新增/删除的文字,不含方向或好坏判断。
未列出(无法可靠提取或缺失):市场风险(第3项)、法律诉讼、其他信息
代表性摘录
每个章节最多 5 条、每条约 300 字符的原文摘录,直接来自两份 SEC 文件。
管理层讨论与分析
相对上期新增的文字 · 来源:10-Q · 2026-08-13
HKHC’s quarterly and year-to-date ETF revenues grew 30% and 32% respectively based on AUM growth at our Inflation Beneficiaries ETF.
The Company’s total management and advisory fees did not change significantly at $18.8 million for both the three months ended June 30, 2026 and 2025, respectively. HKHC’s quarterly ETF revenues grew $0.8 million, or 30%, based primarily on AUM growth at our Inflation Beneficiaries ETF. The Company …
For the three months ended June 30, 2026, sales, distribution and marketing expenses decreased $0.3 million, or 8%, compared to the prior year, primarily as a result of lower platform fees compared to the second quarter of 2025.
Other income (expense) was ($0.2 million) for the three months ended June 30, 2026 compared to $0.2 million in the prior year period. During the three months ended June 30, 2026, the Company recognized a decrease in the fair value of one of its other investments by $4.8 million and was partially off…
For the three months ended June 30, 2026, the Company recognized an unrealized loss on investments of $8.0 million, compared to an unrealized loss of $15.4 million during the second quarter of the prior year. This change was due primarily to the decrease in the fair value of TPL during the three mon…
相对上期删除的文字 · 来源:10-Q · 2026-05-15
HKHC’s revenues from ETF products increased $0.8 million, or 34.0%, this quarter primarily as a result of higher average AUM at our Inflation Beneficiaries ETF.
The Company’s total management and advisory fees decreased approximately $0.7 million, or 3.7%, for the three months ended March 31, 2026 compared to the prior year. The decrease is primarily the result of lower management fees from our mutual funds, however those were declines were partially offset…
For the three months ended March 31, 2026, sales, distribution and marketing expenses increased $0.8 million, or 20%, compared to the prior quarter, primarily as a result of a higher expense to FRMO pursuant to its revenue sharing agreement with HKHC of $0.8 million that was associated solely to the…
During the year ended March 31, 2026, the Company recorded a gain of $5.9 million related to one of its private investments being acquired. The Company received $0.5 million of cash and $5.2 million of another equity security in a private entity as a result of the transaction.
For the three months ended March 31, 2026, unrealized gains (losses) on investments increased by $22.4 million compared to the prior year. This increase was due primarily to the $32.4 million unrealized gain on TPL stock during the three months ended March 31, 2026 resulting from its approximately 6…
如何读 10-Q 的风险因素(第 1A 项)
10-Q 的风险因素章节有三种常见形态,本页按其一分类展示:
- 指向(pointer) — 公司仅声明"无重大变化"并指向年度 10-K 的完整风险因素;本季没有自己的风险文本可对比。
- 部分更新(partial) — 公司写明"除下述外无重大变化",只更新部分风险;摘录展示的正是本季新增的内容。
- 全文重述(restated) — 本季重新给出完整风险因素。若上一季只是"指向",则无法逐段对比,本页会将其标为"本季全文重述"。
这只是对文件结构的客观描述,不构成对风险高低的判断。
数据来自 SEC EDGAR 两份申报文件的文本级对比 · 确定性计算(无 AI 生成内容)· 仅供参考 · 非投资建议